ABBVIE INC. vs. Xeris Biopharma Holdings, Inc. Common Stock
ABBVIE INC. and Xeris Biopharma Holdings, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABBV | XERS | |
|---|---|---|
| Market Cap | $521.15 billion | $1.98 billion |
ABBV leads on 1 of 1 size & scale factors.
Dividend
| ABBV | XERS | |
|---|---|---|
| Dividend Yield | 2.53% | — |
ABBV and XERS split the dividend factors evenly.
Risk & Sentiment
| ABBV | XERS | |
|---|---|---|
| Short Interest | 0.85% | 0.10% |
XERS leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, XERS overview, XERS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.